MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status

Figure 1

Methylation levels of MEGF10 have high efficiency to predict IDH mutation. (a) Tspair analysis showed that IDH mutation status can be predicted by methylation levels of cg06940792 and cg26025891 in GBM patients. (b, c) Tspair and ROC curve analysis confirmed the high performance of candidates as a predictor of IDH mutation in LGG patients.

(a)

(b)

(c)